Twist Bioscience (TWST) Receivables - Net (2018 - 2026)
Twist Bioscience has reported Receivables - Net over the past 9 years, most recently at $64.2 million for Q1 2026.
- Quarterly Receivables - Net rose 28.44% to $64.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $64.2 million through Mar 2026, up 28.44% year-over-year, with the annual reading at $57.0 million for FY2025, 63.36% up from the prior year.
- Receivables - Net was $64.2 million for Q1 2026 at Twist Bioscience, up from $50.1 million in the prior quarter.
- Over five years, Receivables - Net peaked at $64.2 million in Q1 2026 and troughed at $32.0 million in Q2 2024.
- The 5-year median for Receivables - Net is $42.6 million (2023), against an average of $43.8 million.
- Year-over-year, Receivables - Net dropped 25.31% in 2024 and then soared 63.36% in 2025.
- A 5-year view of Receivables - Net shows it stood at $44.4 million in 2022, then fell by 20.44% to $35.4 million in 2023, then increased by 11.2% to $39.3 million in 2024, then increased by 27.34% to $50.1 million in 2025, then grew by 28.15% to $64.2 million in 2026.
- Per Business Quant, the three most recent readings for TWST's Receivables - Net are $64.2 million (Q1 2026), $50.1 million (Q4 2025), and $57.0 million (Q3 2025).